Kensington Capital Acquisition Corp. Iv KCAC-UN
We take great care to ensure that the data presented and summarized in this overview for Kensington Capital Acquisition Corp. IV is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in KCAC-UN
Top Purchases
Top Sells
About KCAC-UN
Kensington Capital Acquisition Corp. IV focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of the automotive and automotive-related sectors. The company was incorporated in 2021 and is based in Westbury, New York.
Insider Transactions at KCAC-UN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 13
2025
|
Wen Hsuan Hsieh Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+19.17%
|
-
|
Jun 13
2025
|
Donald R Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+10.12%
|
-
|
Jun 13
2025
|
Steven Chu Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+18.97%
|
-
|
Jun 13
2025
|
Kathleen A Bayless Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+17.77%
|
-
|
Jun 13
2025
|
Livingston Satterthwaite Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,444
+11.68%
|
-
|
May 21
2025
|
Sandra Wallach Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,595
-2.6%
|
$55,190
$2.43 P/Share
|
May 21
2025
|
Constantin Ionel Stefan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
20,366
-2.3%
|
$40,732
$2.43 P/Share
|
May 21
2025
|
Kang Sun Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
69,786
-3.71%
|
$139,572
$2.43 P/Share
|
May 01
2025
|
Thomas M Stepien President |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+50.0%
|
-
|
Mar 19
2025
|
Kang Sun Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
599,400
+24.16%
|
-
|
Mar 19
2025
|
Constantin Ionel Stefan Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
461,540
+34.24%
|
-
|
Mar 19
2025
|
Sandra Wallach Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
383,260
+26.53%
|
-
|
Mar 14
2025
|
Constantin Ionel Stefan Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,471
+0.81%
|
$0
$0.98 P/Share
|
Mar 10
2025
|
Jonathan Bornstein President of Amprius Lab |
BUY
Exercise of conversion of derivative security
|
Direct |
3,471
+0.81%
|
$0
$0.98 P/Share
|
Feb 21
2025
|
Sandra Wallach Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,142
-2.61%
|
$54,426
$3.13 P/Share
|
Feb 21
2025
|
Kang Sun Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,353
-2.61%
|
$103,059
$3.13 P/Share
|
Feb 21
2025
|
Jonathan Bornstein President of Amprius Lab |
SELL
Open market or private sale
|
Direct |
13,527
-3.13%
|
$40,581
$3.13 P/Share
|
Feb 21
2025
|
Constantin Ionel Stefan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
9,066
-2.11%
|
$27,198
$3.13 P/Share
|
Nov 21
2024
|
Sandra Wallach Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,158
-2.41%
|
$17,158
$1.96 P/Share
|
Nov 21
2024
|
Jonathan Bornstein President of Amprius Lab |
SELL
Open market or private sale
|
Direct |
18,170
-3.85%
|
$18,170
$1.96 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 3.28M shares |
---|---|
Exercise of conversion of derivative security | 6.94K shares |
Open market or private sale | 1.23M shares |
---|---|
Other acquisition or disposition | 62.7M shares |